us-gaap |
Net Income (Loss) Attributable to Parent |
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
View
|
us-gaap |
Operating Income (Loss) |
The net result for the period of deducting operating expenses from operating revenues. |
View
|
us-gaap |
Operating Leases, Future Minimum Payments Due |
Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent |
Purchase price of common stock expressed as a percentage of its fair value. |
View
|
us-gaap |
Deferred Tax Assets, Goodwill and Intangible Assets |
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill. |
View
|
us-gaap |
Deferred Tax Assets, Gross |
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. |
View
|
dei |
Entity Public Float |
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. |
View
|
us-gaap |
Accrued Professional Fees |
Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. |
View
|
us-gaap |
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment |
Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services. |
View
|
us-gaap |
Accumulated Other Comprehensive Income (Loss), Net of Tax |
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge. |
View
|
us-gaap |
Additional Paid in Capital |
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. |
View
|
us-gaap |
APIC, Share-based Payment Arrangement, Increase for Cost Recognition |
Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
View
|
us-gaap |
Share-based Payment Arrangement, Expense |
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. |
View
|
us-gaap |
Amortization of Intangible Assets |
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. |
View
|
us-gaap |
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount |
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. |
View
|
us-gaap |
Asset Impairment Charges |
Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. |
View
|
us-gaap |
Assets |
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. |
View
|
us-gaap |
Assets, Current |
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. |
View
|
us-gaap |
Assets Held-for-sale, Current (Deprecated 2014-01-31) |
Current assets (normally turning over within one year or one business cycle if longer) that are held for sale apart from normal operations and anticipated to be sold within one year. |
View
|
us-gaap |
Available-for-sale Securities |
Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading. |
View
|
us-gaap |
Available-for-sale Securities, Gross Unrealized Gain |
Amount of unrealized gain before deducting unrealized loss on investments in debt and equity securities classified as available-for-sale securities. |
View
|
us-gaap |
Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) |
This item represents the gross unrealized losses for securities, at a point in time, which are categorized neither as held-to-maturity nor trading securities. |
View
|
us-gaap |
Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) |
This item represents the gross unrealized gains for securities, at a point in time, which are categorized neither as held-to-maturity nor trading securities. |
View
|
us-gaap |
Business Combination, Acquisition Related Costs |
This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. |
View
|
us-gaap |
Cash and Cash Equivalents, at Carrying Value |
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
View
|
us-gaap |
Cash and Cash Equivalents, Period Increase (Decrease) |
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. |
View
|
us-gaap |
Common Stock, Par or Stated Value Per Share |
Face amount or stated value per share of common stock. |
View
|
us-gaap |
Common Stock, Shares Authorized |
The maximum number of common shares permitted to be issued by an entity's charter and bylaws. |
View
|
us-gaap |
Common Stock, Shares, Issued |
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. |
View
|
us-gaap |
Common Stock, Shares, Outstanding |
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. |
View
|
us-gaap |
Common Stock, Value, Issued |
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
View
|
us-gaap |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
View
|
us-gaap |
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest |
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners. |
View
|
us-gaap |
Costs and Expenses |
Total costs of sales and operating expenses for the period. |
View
|
us-gaap |
Deferred Federal Income Tax Expense (Benefit) |
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations. |
View
|
us-gaap |
Deferred Tax Assets, Operating Loss Carryforwards |
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. |
View
|
us-gaap |
Deferred Tax Assets, Operating Loss Carryforwards, State and Local |
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards. |
View
|
us-gaap |
Deferred Tax Assets, Other |
Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other. |
View
|
us-gaap |
Deferred Tax Assets, Property, Plant and Equipment |
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment. |
View
|
us-gaap |
Deferred Tax Assets, Tax Credit Carryforwards, Other |
Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible tax credit carryforwards, classified as other. |
View
|
us-gaap |
Deferred Tax Assets, Tax Credit Carryforwards, Research |
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. |
View
|
us-gaap |
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost |
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. |
View
|
us-gaap |
Deferred Tax Assets, Valuation Allowance |
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. |
View
|
us-gaap |
Defined Benefit Plan, Plan Assets, Contributions by Employer |
Amount of contribution received by defined benefit plan from employer which increases plan assets. |
View
|
us-gaap |
Defined Contribution Plan, Employer Matching Contribution, Percent of Match |
Percentage employer matches of the employee's percentage contribution matched. |
View
|
us-gaap |
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent |
Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan. |
View
|
us-gaap |
Depreciation |
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. |
View
|
us-gaap |
Depreciation, Depletion and Amortization |
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
View
|
us-gaap |
Dividends, Cash |
Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred. |
View
|
us-gaap |
Dividends Payable, Amount Per Share |
The per share amount of a dividend declared, but not paid, as of the financial reporting date. |
View
|
us-gaap |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
Percentage of domestic federal statutory tax rate applicable to pretax income (loss). |
View
|
us-gaap |
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent |
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets. |
View
|
us-gaap |
Effective Income Tax Rate Reconciliation, Other Adjustments, Percent |
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. |
View
|
us-gaap |
Impairment of Long-Lived Assets Held-for-use |
The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale). |
View
|
us-gaap |
Impairment of Long-Lived Assets to be Disposed of |
The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale. |
View
|
us-gaap |
Income Tax Expense (Benefit) |
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
View
|
us-gaap |
Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability |
Amount of income tax expense (benefit) from continuing operations attributable to an adjustment of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity. |
View
|
us-gaap |
Increase (Decrease) in Accounts Payable |
The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
View
|
us-gaap |
Increase (Decrease) in Accounts Receivable |
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
View
|
us-gaap |
Increase (Decrease) in Accrued Liabilities |
The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
View
|
us-gaap |
Increase (Decrease) in Other Operating Assets |
Amount of increase (decrease) in operating assets classified as other. |
View
|
us-gaap |
Increase (Decrease) in Prepaid Expense |
The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. |
View
|
us-gaap |
Disposal Group, Including Discontinued Operation, Inventory, Current (Deprecated 2015-01-31) |
Amount classified as inventory attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer. |
View
|
us-gaap |
Investment Income, Interest |
Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. |
View
|
us-gaap |
Investments, Fair Value Disclosure |
Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method. |
View
|
us-gaap |
Leasehold Improvements, Gross |
Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement. |
View
|
us-gaap |
Liabilities and Equity |
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
View
|
us-gaap |
Liabilities, Current |
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
View
|
us-gaap |
Machinery and Equipment, Gross |
Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment. |
View
|
us-gaap |
Marketable Securities, Current |
Amount of investment in marketable security, classified as current. |
View
|
us-gaap |
Marketable Securities, Gain (Loss) |
Amount of unrealized and realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI). |
View
|
us-gaap |
Marketable Securities, Noncurrent |
Amount of investment in marketable security, classified as noncurrent. |
View
|
us-gaap |
Marketable Securities, Unrealized Gain (Loss) |
Amount of unrealized gain (loss) on investment in marketable security. |
View
|
us-gaap |
Unsuccessful Business Combination Costs (Deprecated 2013-01-31) |
Amount of direct costs of an unsuccessful business combination including legal, accounting, and other costs that were charged to expense during the period, but may have been capitalized had the contemplated transaction been completed. |
View
|
us-gaap |
Net Cash Provided by (Used in) Financing Activities |
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
View
|
us-gaap |
Net Cash Provided by (Used in) Investing Activities |
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
View
|
us-gaap |
Net Cash Provided by (Used in) Operating Activities |
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. |
View
|
us-gaap |
Operating Leases, Rent Expense, Net |
Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income. |
View
|
us-gaap |
Operating Loss Carryforwards |
Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. |
View
|
us-gaap |
Other Asset Impairment Charges |
The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value. |
View
|
us-gaap |
Other Assets, Noncurrent |
Amount of noncurrent assets classified as other. |
View
|
us-gaap |
Other Nonoperating Income |
Amount of income related to nonoperating activities, classified as other. |
View
|
us-gaap |
Other than Temporary Impairment Losses, Investments, Available-for-sale Securities |
The amount by which the fair value of an investment in debt and equity securities categorized as Available-for-sale is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income. |
View
|
us-gaap |
Payments for Legal Settlements |
The amount of cash paid for the settlement of litigation or for other legal issues during the period. |
View
|
us-gaap |
Payments of Capital Distribution |
Cash outflow to owners or shareholders, excluding ordinary dividends. Includes special dividends. |
View
|
us-gaap |
Payments of Dividends |
Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests. |
View
|
us-gaap |
Payments to Acquire Marketable Securities |
Amount of cash outflow for purchase of marketable security. |
View
|
us-gaap |
Payments to Acquire Property, Plant, and Equipment |
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
View
|
us-gaap |
Preferred Stock Dividends, Shares |
Number of shares of preferred stock issued as dividends during the period. Excludes stock splits. |
View
|
us-gaap |
Preferred Stock, Par or Stated Value Per Share |
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. |
View
|
us-gaap |
Preferred Stock, Shares Authorized |
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. |
View
|
us-gaap |
Preferred Stock, Shares Issued |
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. |
View
|
us-gaap |
Preferred Stock, Shares Outstanding |
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. |
View
|
us-gaap |
Prepaid Expense and Other Assets, Current |
Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
View
|
us-gaap |
Proceeds from Issuance of Common Stock |
The cash inflow from the additional capital contribution to the entity. |
View
|
us-gaap |
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised |
Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised. |
View
|
us-gaap |
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale |
Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). |
View
|
us-gaap |
Proceeds from Sale and Maturity of Marketable Securities |
The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period. |
View
|
us-gaap |
Proceeds from Sale of Available-for-sale Securities |
The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities. |
View
|
us-gaap |
Proceeds from Sale of Productive Assets |
The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets. |
View
|
us-gaap |
Proceeds from Stock Plans |
The cash inflow associated with the amount received from the stock plan during the period. |
View
|
us-gaap |
Property, Plant and Equipment, Net |
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
View
|
us-gaap |
Retained Earnings (Accumulated Deficit) |
The cumulative amount of the reporting entity's undistributed earnings or deficit. |
View
|
us-gaap |
Revenues |
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
View
|
us-gaap |
Severance Costs (Deprecated 2013-01-31) |
The charge against earnings in the period for known and estimated costs of termination benefits provided to current employees that are involuntarily terminated under a benefit arrangement associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, excluding costs or losses pertaining to an entity newly acquired in a business combination or a discontinued operation as defined by generally accepted accounting principles and costs associated with one-time termination benefits. |
View
|
us-gaap |
Severance Costs |
Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation. |
View
|
us-gaap |
Share-based Payment Arrangement, Noncash Expense |
Amount of noncash expense for share-based payment arrangement. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period |
The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value |
Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period |
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value |
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number |
The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period |
For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price |
Weighted average price of options that were either forfeited or expired. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross |
Gross number of share options (or share units) granted during the period. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value |
The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number |
Number of options outstanding, including both vested and non-vested options. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price |
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number |
Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price |
Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. |
View
|
us-gaap |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price |
Weighted average price at which option holders acquired shares when converting their stock options into shares. |
View
|
us-gaap |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price |
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. |
View
|
us-gaap |
Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit |
The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range. |
View
|
us-gaap |
Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable |
The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied. |
View
|
us-gaap |
Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding |
The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices. |
View
|
us-gaap |
Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit |
The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. |
View
|
us-gaap |
Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price |
The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices. |
View
|
us-gaap |
Stock Issued During Period, Shares, Employee Stock Purchase Plans |
Number of shares issued during the period as a result of an employee stock purchase plan. |
View
|
us-gaap |
Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) |
Number of shares issued as consideration for cash for development stage entities. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period |
Number of share options (or share units) exercised during the current period. |
View
|
us-gaap |
Stock Issued During Period, Value, New Issues |
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
View
|
us-gaap |
Unrecognized Tax Benefits |
Amount of unrecognized tax benefits. |
View
|
us-gaap |
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued |
Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return. |
View
|
us-gaap |
Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions |
Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return. |
View
|
us-gaap |
Unrecognized Tax Benefits, Period Increase (Decrease) |
Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns. |
View
|
us-gaap |
Weighted Average Number of Shares Outstanding, Basic and Diluted |
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). |
View
|
dei |
Entity Common Stock, Shares Outstanding |
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. |
View
|
us-gaap |
Accounts Payable, Current |
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
View
|
us-gaap |
Accrued Liabilities, Current |
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
View
|
us-gaap |
Available-for-sale Securities, Amortized Cost Basis |
This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any. |
View
|
us-gaap |
Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) |
This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale. |
View
|
us-gaap |
Deferred Tax Assets, in Process Research and Development |
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination. |
View
|
us-gaap |
Earnings Per Share, Basic and Diluted |
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. |
View
|
us-gaap |
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent |
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit). |
View
|
us-gaap |
Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount |
Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options. |
View
|
us-gaap |
Employee Stock Ownership Plan (ESOP), Compensation Expense |
The amount of plan compensation cost recognized during the period. |
View
|
us-gaap |
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property |
Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property. |
View
|
us-gaap |
Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) |
The gains (losses) included in results of operations resulting from the sale or disposal of property, plant and equipment, which do not qualify for treatment as discontinued operations. This item does not include any gain (loss) recognized on the sale of oil and gas property or timber property. |
View
|
us-gaap |
General and Administrative Expense |
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
View
|
us-gaap |
Operating Leases, Future Minimum Payments Due, Next Twelve Months |
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. |
View
|
us-gaap |
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax |
Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
View
|
us-gaap |
Professional Fees |
A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. |
View
|
us-gaap |
Property, Plant and Equipment, Gross |
Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
View
|
us-gaap |
Research and Development Expense |
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number |
The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value |
Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period |
The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value |
The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate |
The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate |
The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate |
The risk-free interest rate assumption that is used in valuing an option on its own shares. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized |
Number of shares authorized for issuance under share-based payment arrangement. |
View
|
us-gaap |
Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price |
Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding. |
View
|
us-gaap |
Stockholders' Equity Attributable to Parent |
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. |
View
|